Unifying Acquisitions Under One Instem Brand
A strategic evolution that will help you move faster, make more informed decisions, and deliver greater value through your research.
A strategic evolution that will help you move faster, make more informed decisions, and deliver greater value through your research.
Advancing Non-GLP In Vivo Research with Speed, Flexibility, and Scientific Focus.
Instem has completed its acquisition of Xybion Digital, creator of the Pristima™ preclinical study management platform.
Instem Strengthens Preclinical Capabilities with RockStep Acquisition and Climb™ Integration
This release includes significant feature advancements, a new web-based module, and broad support for digital workflow adoption.
As clinical trials transparency needs grow, life sciences teams need more than anonymization—they need a full clinical trial transparency platform.